Implementation of the COmmunity HEalth System InnovatiON Project in Low- and Middle- Income Countries

NCT ID: NCT06989502

Last Updated: 2025-05-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

2094 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-05-17

Study Completion Date

2026-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The COHESION-I project will evaluate the effects of the co-creation intervention (2016 to 2019) and the co-design intervention (2023 to 2024) on improving (a) health system responsiveness, and (b) patient satisfaction, at the primary health care level, in Peru, Nepal and Mozambique, in relation to chronic diseases (hypertension, and diabetes mellitus), as well as specific neglected tropical diseases. Each intervention has been tailored to the context and characteristics of each one of the aforementioned low- and middle-income countries.

For this quasi-experimental study, three arms were established: the co-creation (2016 to 2019) + co-design (2023 to 2024) arm; the co-design only (2023 to 2024) arm; and the control group (no intervention; usual care). The evaluation will be composed of four types of evaluations: quantitative; qualitative; economic; and process evaluation

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The COHESION-I project (I is for Intervention) has two main objectives: first, to implement and evaluate the context specific co-created interventions in the three countries - Mozambique, Nepal, and Peru (Component 1), and second, to explore the possibilities to transfer the experience and lessons learnt to other countries (India) for adaptation of such intervention approach in a different context (Component 2). COHESION-I continues and is based on a previous project called COHESION. The previous project, The COmmunity HEalth System InnovatiON (COHESION) project was a 4-year project that started in 2016 as a collaboration between research teams from Mozambique, Nepal, Peru and Switzerland. It enabled formative research to be conducted at policy, health system and community levels using tracer chronic conditions that included non-communicable diseases (NCDs) (diabetes and hypertension), and a specific neglected tropical disease (NTDs) (Schistosomiasis in Mozambique, Leprosy in Nepal and Epilepsy resulting from neurocysticercosis in Peru). The results from this formative research were utilised as part of a process for identifying adequate interventions through a participatory approach with communities, primary healthcare (PHC) workers, and regional health authorities. Meetings with different stakeholders were carried out between 2017 and 2018 to propose context- relevant interventions oriented to address the challenges of providing care for people affected by NCDs and NTDs. During the meetings, participants provided feedback regarding problems and potential solutions for chronic care and health services in general and proposed possible areas of intervention. Upon completion of all the meetings, each country identified the main components to be included in their interventions that were focussed on communities, healthcare workers and facilities. For example, the suggested intervention components in Mozambique include: (i) radio programs, spots, or podcasts and pamphlets to inform population about hypertension, (ii) development of facility-based guideline/algorithm, training in hypertension and clear communication, and group discussions on challenges and opportunities to manage chronic diseases, and (iii) establishment of a medical appointment system for people with chronic diseases.

In this new phase, the COHESION-I project, which will be conducted from 2022 to 2026, the impact of a co-creation/co-design strategy will be evaluated in terms of two main outcomes: on the one hand, improved health system responsiveness at primary care level and patient satisfaction and, on the other hand, improved health care for chronic diseases. The general research objective of COHESION-I is to implement and evaluate at the primary health care level the co-created/co-designed interventions in the selected settings in each of the three countries (Mozambique, Nepal and Peru), focusing on Non-Communicable Diseases (diabetes, hypertension) and Neglected Tropical Diseases (schistosomiasis in Mozambique, Leprosy in Nepal and neurocysticercosis in Peru). This study involves the following evaluation components: quantitative evaluation, qualitative evaluation, economic evaluation, and process evaluation. There will be five trimesters in total for undertaking these different types of evaluations.

This study will implement a mixed-methods approach that includes a pre-post quasi-experimental study: a quantitative component that will accrue an initial survey and five repeated measurements over time with an embedded qualitative study.The study will be developed in three low- and middle-income countries: Mozambique, Nepal and Peru. In each country, the COHESION-I project will be implemented in six sites (A, B, C, D, E and F). From these six sites, two of them have already been selected (A and B sites). The A and B sites are the ones where the co-creation process was conducted between 2016 - 2019, and now, during the current phase, receive the co-designed intervention (co-created + co-designed). Sites C and D have been selected and they have similar characteristics as sites A and B. The difference is that in the previous phase of the COHESION project did not hold any previous activity in these settings. Participants in sites C and D are being engaged for the first time and will receive the same co-designed intervention as sites A and B, but without having been involved in the co-creation process (2016 to 2019). Finally, sites E and F, will share similar characteristics as sites A, B, C, and D, but they will receive no intervention (control sites or usual care).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension Diabetes Mellitus Neglected Tropical Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Co-creation (2016 to 2019) + Co-design (2023 to 2024)

PERU:

* Radio programs with content related to health care
* Capacity building on management of diabetes, hypertension and neurocysticercosis
* Communication jar to prompt communication between health workers and patients
* Decentralized decision-making on facility improvement

NEPAL:

* Radio and pamphlets to promote Primary Health Care (PHC)
* Involvement of Female Community Health Volunteers
* Capacity building on management of diabetes, hypertension and lepra
* Flip charts, guidelines and posters for management of diseases and to prompt communication between health workers and patients
* Decentralized decision-making on facility improvement

MOZAMBIQUE:

* Radio and pamphlets informing population on hypertension, PHC and appointment system
* Facility based guideline/algorithm
* Capacity building on hypertension, diabetes and schistosomiasis
* Establishment of an "information booth"
* Group discussions on challenges and opportunities
* Advocacy on the issue of access to medicines

Group Type EXPERIMENTAL

Co-creation (2016 to 2019) + Co-design (2023 to 2024)

Intervention Type BEHAVIORAL

It includes interventions implemented in a sequential way: a) The co-creation intervention (between 2016 and 2019), and b) the co-design intervention (between 2023 and 2024).

In this group of sequential interventions, relevant stakeholders have already been engaged in the project and they would be familiar with the intervention components. Their participation this time will enable updating and refining the previous co-creation intervention through the co-design process.

The intervention will encompass activities with the health service users and healthcare workers, in Peru, Nepal, and Mozambique

Co-design only (2023 to 2024)

PERU:

* Radio programs with content related to health care
* Capacity building on management of diabetes, hypertension and neurocysticercosis
* Communication jar to prompt communication between health workers and patients
* Decentralized decision-making on facility improvement

NEPAL:

* Radio and pamphlets to promote Primary Health Care (PHC)
* Involvement of Female Community Health Volunteers
* Capacity building on management of diabetes, hypertension and lepra
* Flip charts, guidelines and posters for management of diseases and to prompt communication between health workers and patients
* Decentralized decision-making on facility improvement

MOZAMBIQUE:

* Radio and pamphlets informing population on hypertension, PHC and appointment system
* Facility based guideline/algorithm
* Capacity building on hypertension, diabetes and schistosomiasis
* Establishment of an "information booth"
* Group discussions on challenges and opportunities
* Advocacy on the issue of access to medicines

Group Type EXPERIMENTAL

Co-design only (2023 to 2024)

Intervention Type BEHAVIORAL

The same intervention activities of the first group (between 2023 and 2024), but without having them involved in the previous co-creation process. In consequence, relevant stakeholders in the corresponding sites are not expected to be as engaged in the project (in contrast to the intervention that includes co-creation), and they would not be very familiar with the intervention components of COHESION-I.

As in the first group, the intervention will encompass activities with the health service users and healthcare workers, in Peru, Nepal, and Mozambique

Control

Usual care, understood as the Primary Health Care (PHC) that the target patient population receives as part of the conventional or usual medical practice in each of their communities, in Peru, Nepal, and Mozambique

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Co-creation (2016 to 2019) + Co-design (2023 to 2024)

It includes interventions implemented in a sequential way: a) The co-creation intervention (between 2016 and 2019), and b) the co-design intervention (between 2023 and 2024).

In this group of sequential interventions, relevant stakeholders have already been engaged in the project and they would be familiar with the intervention components. Their participation this time will enable updating and refining the previous co-creation intervention through the co-design process.

The intervention will encompass activities with the health service users and healthcare workers, in Peru, Nepal, and Mozambique

Intervention Type BEHAVIORAL

Co-design only (2023 to 2024)

The same intervention activities of the first group (between 2023 and 2024), but without having them involved in the previous co-creation process. In consequence, relevant stakeholders in the corresponding sites are not expected to be as engaged in the project (in contrast to the intervention that includes co-creation), and they would not be very familiar with the intervention components of COHESION-I.

As in the first group, the intervention will encompass activities with the health service users and healthcare workers, in Peru, Nepal, and Mozambique

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Males or females aged 18 years and over, from the selected sites
* Having used the health services in the previous three months
* Diagnosis (or estimated risk) of diabetes mellitus type 2, hypertension, or neurocysticercosis
* Must be able to listen to radio programs, or other audio material


* Males or females aged 18 years and over, from the selected sites
* Having used the health services in the previous three months
* Must be able to listen to radio programs, or other audio material

Exclusion Criteria

\- Diagnosis (or estimated risk) of diabetes mellitus type 2, hypertension, or neurocysticercosis

The criteria mentioned above refer solely to the quantitative evaluation. For the other types of evaluation, some different populations will be included (such as healthcare workers, local authorities and other stakeholders).
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Eduardo Mondlane University

OTHER

Sponsor Role collaborator

B.P. Koirala Institute of Health Sciences

OTHER

Sponsor Role collaborator

Universidad Peruana Cayetano Heredia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

María Lazo Porras

Research Associate at CRONICAS

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

María Lazo-Porras, MD, MSc, PhD

Role: PRINCIPAL_INVESTIGATOR

Universidad Peruana Cayetano Heredia

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Eduardo Mondlane University

Maputo, , Mozambique

Site Status

B.P. Koirala Institute of Health Sciences

Dharān, , Nepal

Site Status

Universidad Peruana Cayetano Heredia

Piura, , Peru

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Mozambique Nepal Peru

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

María Lazo-Porras, MD, MSc, PhD

Role: CONTACT

511-2416978

Antonio Bernabe-Ortiz, MD, MPH, PhD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Albertino Damasceno, MD, PhD

Role: primary

Sanjib Sharma, MD

Role: primary

María Lazo-Porras, MD, MSc, PhD

Role: primary

Antonio Bernabe-Ortiz, MD, MPH, PhD

Role: backup

References

Explore related publications, articles, or registry entries linked to this study.

Beran D, Lazo-Porras M, Cardenas MK, Chappuis F, Damasceno A, Jha N, Madede T, Lachat S, Perez Leon S, Aya Pastrana N, Pesantes MA, Singh SB, Sharma S, Somerville C, Suggs LS, Miranda JJ. Moving from formative research to co-creation of interventions: insights from a community health system project in Mozambique, Nepal and Peru. BMJ Glob Health. 2018 Nov 16;3(6):e001183. doi: 10.1136/bmjgh-2018-001183. eCollection 2018.

Reference Type BACKGROUND
PMID: 30498592 (View on PubMed)

Pesantes MA, Somerville C, Singh SB, Perez-Leon S, Madede T, Suggs S, Beran D. Disruption, changes, and adaptation: Experiences with chronic conditions in Mozambique, Nepal and Peru. Glob Public Health. 2020 Mar;15(3):372-383. doi: 10.1080/17441692.2019.1668453. Epub 2019 Oct 9.

Reference Type BACKGROUND
PMID: 31596656 (View on PubMed)

Cardenas MK, Perez-Leon S, Singh SB, Madede T, Munguambe S, Govo V, Jha N, Damasceno A, Miranda JJ, Beran D. Forty years after Alma-Ata: primary health-care preparedness for chronic diseases in Mozambique, Nepal and Peru. Glob Health Action. 2021 Jan 1;14(1):1975920. doi: 10.1080/16549716.2021.1975920.

Reference Type BACKGROUND
PMID: 34569443 (View on PubMed)

Bernabe-Ortiz A, Perel P, Miranda JJ, Smeeth L. Diagnostic accuracy of the Finnish Diabetes Risk Score (FINDRISC) for undiagnosed T2DM in Peruvian population. Prim Care Diabetes. 2018 Dec;12(6):517-525. doi: 10.1016/j.pcd.2018.07.015. Epub 2018 Aug 18.

Reference Type BACKGROUND
PMID: 30131300 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

https://www.cronicas-upch.pe/en/implementation-of-the-community-health-system-innovation-project-in-low-and-middle-income-countries-cohesion-i/

COHESION-I project description, hosted at the website of CRONICAS Center of Excellence in Chronic Diseases, at Universidad Peruana Cayetano Heredia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NIHR150261

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.